Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-06-05 23:09:56 |
Versijas komentārs | |
Teksts |
First Quarter 2014 Investor Conference Webinar
On June 5 AS „Olainfarm” organized its first quarter 2014 Investor
Conference Online Webinar. During the webinar the member of the
management board of AS „Olainfarm” Salvis Lapiņš analysed the
financial results of first quarter 2014 and informed about the
company’s future activities, paying a lot of attention to
Belarusian market.
The recorded “Olainfarm” webinar is available online:
http://ej.uz/Olainfarm_1Q_webinar_2014,
and the presentation, demonstrated during the webinar, can be found
in the previously published AS “Olainfarm” announcement:
https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=612858&messageId=759535.
Olainfarm thanks all participants, who joined the webinar, and
encourages everybody to follow company’s announcements to get
information on the next webinar!
JSC Olainfarm is one of the biggest pharmaceutical companies in
Latvia with more than 40 years of experience in production of
medication and chemical and pharmaceutical products. A basic
principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the
world. Products made by the Group are being exported to more than
35 countries of the world, including the Baltics, Russia, other
CIS, Europe, Asia, North America and Australia.
Information prepared
by: Salvis Lapins |
Pielikumi |
|